posaconazole 300 MG per 16.7 ML Injection
- RxCUI
- 1492043
- RxNorm name
- posaconazole 300 MG per 16.7 ML Injection
- Display name
- posaconazole 300 MG per 16.7 ML Injection
- Full name
- posaconazole 300 MG per 16.7 ML Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:16
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| posaconazole | POSACONAZOLE | Mylan Institutional LLC | 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | 2026-07-15 | Warnings, Adverse reactions | 1492043 |
| posaconazole | POSACONAZOLE | Gland Pharma Limited | 52d9d29e-4a37-4926-aa57-8477f5447b34 | 2026-06-09 | Warnings, Adverse reactions | 1492043 |
| NOXAFIL | POSACONAZOLE | Merck Sharp & Dohme LLC | b073b082-7b57-4423-8c06-4fd4263d6f84 | 2026-02-13 | Warnings, Adverse reactions | 1492043 |
| posaconazole | POSACONAZOLE | GLENMARK PHARMACEUTICALS INC., USA | a2ba0343-cd17-4b23-8356-005a1dfd0b35 | 2026-02-11 | Warnings, Adverse reactions | 1492043 |
| posaconazole | POSACONAZOLE | GLENMARK PHARMACEUTICALS INC., USA | 91f89a3b-2479-4d05-9997-7b0cfaa496ec | 2026-02-11 | Warnings, Adverse reactions | 1492043 |
| Posaconazole | POSACONAZOLE | Par Health USA, LLC | 4032672e-1bb0-427d-a3b3-09cda4beaf34 | 2026-01-20 | Warnings, Adverse reactions | 1492043 |
| POSACONAZOLE | POSACONAZOLE | Eugia US LLC | 2e88e379-b712-4dec-97a2-c90ef3638372 | 2025-06-07 | Warnings, Adverse reactions | 1492043 |
| POSACONAZOLE | POSACONAZOLE | Camber Pharmaceuticals, Inc. | c551e121-d5fc-4b35-ba9f-72ce3a314fdc | 2025-01-31 | Warnings, Adverse reactions | 1492043 |
| Posaconazole | POSACONAZOLE | Fresensius Kabi USA, LLC | 86be8cdb-c991-4754-b8f4-1ab79ac40bda | 2023-12-31 | Warnings, Adverse reactions | 1492043 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b073b082-7b57-4423-8c06-4fd4263d6f84 | posaconazole 300 MG in 16.7 ML Injection | PSN | 56 | These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL ® (posaconazole) injection, for intravenous use NOXAFIL ® (posaconazole) delayed-release tablets, for oral use NOXAFIL ® (posaconazole) oral suspension NOXAFIL ® POWDERMIX (posaconazole) for delayed-release oral suspension Initial U.S. Approval: 2006 | 20260213 |
| b073b082-7b57-4423-8c06-4fd4263d6f84 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 56 | These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL ® (posaconazole) injection, for intravenous use NOXAFIL ® (posaconazole) delayed-release tablets, for oral use NOXAFIL ® (posaconazole) oral suspension NOXAFIL ® POWDERMIX (posaconazole) for delayed-release oral suspension Initial U.S. Approval: 2006 | 20260213 |
| b073b082-7b57-4423-8c06-4fd4263d6f84 | posaconazole 300 MG per 16.7 ML Injection | SY | 56 | These highlights do not include all the information needed to use NOXAFIL safely and effectively. See full prescribing information for NOXAFIL. NOXAFIL ® (posaconazole) injection, for intravenous use NOXAFIL ® (posaconazole) delayed-release tablets, for oral use NOXAFIL ® (posaconazole) oral suspension NOXAFIL ® POWDERMIX (posaconazole) for delayed-release oral suspension Initial U.S. Approval: 2006 | 20260213 |
| 4032672e-1bb0-427d-a3b3-09cda4beaf34 | posaconazole 300 MG per 16.7 ML Injection | SY | 20 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260120 |
| 4032672e-1bb0-427d-a3b3-09cda4beaf34 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 20 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260120 |
| 4032672e-1bb0-427d-a3b3-09cda4beaf34 | posaconazole 300 MG in 16.7 ML Injection | PSN | 20 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260120 |
| 52d9d29e-4a37-4926-aa57-8477f5447b34 | posaconazole 300 MG per 16.7 ML Injection | SY | 8 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241125 |
| 52d9d29e-4a37-4926-aa57-8477f5447b34 | posaconazole 300 MG in 16.7 ML Injection | PSN | 8 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241125 |
| 52d9d29e-4a37-4926-aa57-8477f5447b34 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 8 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241125 |
| 2e88e379-b712-4dec-97a2-c90ef3638372 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 3 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250607 |
| 2e88e379-b712-4dec-97a2-c90ef3638372 | posaconazole 300 MG in 16.7 ML Injection | PSN | 3 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250607 |
| 2e88e379-b712-4dec-97a2-c90ef3638372 | posaconazole 300 MG per 16.7 ML Injection | SY | 3 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250607 |
| 91f89a3b-2479-4d05-9997-7b0cfaa496ec | posaconazole 300 MG per 16.7 ML Injection | SY | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| 91f89a3b-2479-4d05-9997-7b0cfaa496ec | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| 91f89a3b-2479-4d05-9997-7b0cfaa496ec | posaconazole 300 MG in 16.7 ML Injection | PSN | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| a2ba0343-cd17-4b23-8356-005a1dfd0b35 | posaconazole 300 MG per 16.7 ML Injection | SY | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| a2ba0343-cd17-4b23-8356-005a1dfd0b35 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| a2ba0343-cd17-4b23-8356-005a1dfd0b35 | posaconazole 300 MG in 16.7 ML Injection | PSN | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20260211 |
| 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | posaconazole 300 MG in 16.7 ML Injection | PSN | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241216 |
| 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241216 |
| 1ebbd88b-547b-4b49-ab73-98094a2d5a79 | posaconazole 300 MG per 16.7 ML Injection | SY | 2 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20241216 |
| c551e121-d5fc-4b35-ba9f-72ce3a314fdc | posaconazole 300 MG per 16.7 ML Injection | SY | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250131 |
| c551e121-d5fc-4b35-ba9f-72ce3a314fdc | posaconazole 300 MG in 16.7 ML Injection | PSN | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250131 |
| c551e121-d5fc-4b35-ba9f-72ce3a314fdc | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. POSACONAZOLE injection, for intravenous use Initial U.S. Approval: 2006 | 20250131 |
| 86be8cdb-c991-4754-b8f4-1ab79ac40bda | posaconazole 300 MG in 16.7 ML Injection | PSN | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. Posaconazole injection, for intravenous use Initial U.S. Approval: 2006 | 20231231 |
| 86be8cdb-c991-4754-b8f4-1ab79ac40bda | posaconazole 300 MG per 16.7 ML Injection | SY | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. Posaconazole injection, for intravenous use Initial U.S. Approval: 2006 | 20231231 |
| 86be8cdb-c991-4754-b8f4-1ab79ac40bda | 16.7 ML posaconazole 18 MG/ML Injection | SCD | 1 | These highlights do not include all the information needed to use POSACONAZOLE INJECTION safely and effectively. See full prescribing information for POSACONAZOLE INJECTION. Posaconazole injection, for intravenous use Initial U.S. Approval: 2006 | 20231231 |